Hetero Drugs Ltd. has introduced a cut-price generic version of Gilead Sciences Inc.’s HIV therapy Biktarvy (bictegravir 50mg/emtricitabine 200mg/tenofovir alafenamide 25mg tablets) in India, the first such version to hit the market under a broad licensing deal provided by the US firm to a large group of local firms.
Gilead told Scrip that it had provided rights to Hetero under a voluntary license to produce generic versions of Biktarvy...





![Spotlight On RDCs, AOCs As Leading Novel Bioconjugates[Updated]](https://web.insights.norstella-labs.com/resizer/v2/3M7ZAWZOBNK7NG4A4WDOIFG6DU.jpg?smart=true&auth=392a1fdb3cfacb29445720c412410e598dbcc5f90f14857652cd498bd0faa0fb&width=400&height=225)
